Postoperative ileus is a serious $6B problem with no good solutions. Patients suffer, and hospital incur excess expense. Noleus reduces postop ileus by treating the intestinal swelling that causes post-operative bowel dysfunction. There is a $3.4B market and we can save hospitals money, while improving patient outcomes. We have closed a seed round, have IP declared novel, have a working prototype and preliminary data showing safety in animals. Join us to accelerate patient recovery.
Connect with Noleus Technologies, Inc